Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2022-05-13 4:14 pm Unchanged | 13D | NKARTA INC NKTX | GSK plc GSK | 3,161,432 6.8% | 0 (Unchanged) | View |
| 2022-02-14 1:31 pm Purchase | 13G | GSK PLC SPONSORED ADS REPRES T GSK | DODGE & COX | 117,971,700 5.9% | 117,971,700 (New Position) | View |
| 2022-02-10 4:55 pm Purchase | 13G | GENOCEA BIOSCIENCES INC GNCA | GSK plc GSK | 5,861,389 9.9% | 644,000 (+12.34%) | View |
| 2022-02-10 4:51 pm Purchase | 13G | LYELL IMMUNOPHARMA INC LYEL | GSK plc GSK | 30,253,189 12.6% | 30,253,189 (New Position) | View |
| 2022-02-10 4:50 pm Sale | 13G | F-STAR THERAPEUTICS INC FSTX | GSK plc GSK | 802,627 3.9% | -1,295 (-0.16%) | View |
| 2022-02-10 4:48 pm Unchanged | 13D | THERAVANCE BIOPHARMA INC TBPH | GSK plc GSK | 9,644,807 13.1% | 0 (Unchanged) | View |
| 2022-02-10 4:46 pm Purchase | 13G | VIR BIOTECHNOLOGY INC VIR | GSK plc GSK | 8,550,954 6.5% | 1,924,927 (+29.05%) | View |
| 2022-02-07 4:40 pm Purchase | 13G | GSK PLC SPONSORED ADR GSK | BlackRock Inc. BLK | 393,329,341 7.8% | 16,045,078 (+4.25%) | View |
| 2021-09-27 06:01 am Unchanged | 13G | FULCRUM THERAPEUTICS INC FULC | GSK plc GSK | 1,785,714 4.5% | 0 (Unchanged) | View |
| 2021-09-16 5:27 pm Unchanged | 13D | SPERO THERAPEUTICS INC SPRO | GSK plc GSK | 1,740,606 5.4% | 0 (Unchanged) | View |
| 2021-09-16 5:22 pm Sale | 13D | BICYCLE THERAPEUTICS PLC SPONS BCYC | GSK plc GSK | 1,529,561 6% | -86,734 (-5.37%) | View |
| 2021-07-12 4:52 pm Purchase | 13G | CVRX INC CVRX | GSK plc GSK | 1,007,583 5% | 1,007,583 (New Position) | View |
| 2021-05-25 4:24 pm Sale | 13D | INNOVIVA INC INVA | GSK plc GSK | 0 0% | -32,005,260 (Position Closed) | View |
| 2021-04-16 4:17 pm Sale | 13D | BICYCLE THERAPEUTICS PLC SPONS BCYC | GSK plc GSK | 1,616,295 7% | -278,536 (-14.70%) | View |
| 2021-04-08 5:24 pm Sale | 13D | PANDION THERAPEUTICS INC PAND | GSK plc GSK | 0 0% | -2,262,301 (Position Closed) | View |
| 2021-02-12 5:13 pm Unchanged | 13D | INNOVIVA INC INVA | GSK plc GSK | 32,005,260 31.6% | 0 (Unchanged) | View |
| 2021-02-12 5:12 pm Purchase | 13G | GENOCEA BIOSCIENCES INC GNCA | GSK plc GSK | 5,217,389 9.9% | 1,540,622 (+41.90%) | View |
| 2021-02-12 5:10 pm Sale | 13G | PROGYNY INC PGNY | GSK plc GSK | 2,926,957 3.4% | -7,600,000 (-72.20%) | View |
| 2021-01-29 09:54 am Purchase | 13G | GSK PLC SPONSORED ADR GSK | BlackRock Inc. BLK | 377,284,263 7.5% | 1,125,028 (+0.30%) | View |
| 2020-12-07 5:08 pm Sale | 13D | SPERO THERAPEUTICS INC SPRO | GSK plc GSK | 1,740,606 6.4% | -78,872 (-4.33%) | View |